Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
The Journal of Pharmacology and Experimental Therapeutics|April 11, 2020
Evolution of the Systems Pharmacokinetics-Pharmacodynamics Model for Antibody-Drug Conjugates to Characterize Tumor Heterogeneity and In Vivo Bystander EffectAman P Singh, Gail M Seigel, Leiming Guo, et al.Advanced Drug Delivery Reviews|January 24, 2021
Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) modelsEkram Ahmed Chowdhury, Guy Meno-Tetang, Hsueh Yuan Chang, et al.Annals of the New York Academy of Sciences|August 16, 2014
Antibody-drug conjugates: an emerging modality for the treatment of cancerMauricio Leal, Puja Sapra, Sara A Hurvitz, et al.Journal of Natural Products|January 8, 2025
Semisynthesis of Glycosmis pentaphylla Alkaloid Derivatives: Pyranoacridone-Hydroxamic Acid Cytotoxic Conjugates with HDAC and Topoisomerase II α Dual Inhibitory ActivityParusu Kavya Teja, Bao Q Ly, Vinal Upadhyay, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 13, 2013
On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approachNahor Haddish-Berhane, Dhaval K Shah, Dangshe Ma, et al.Pharmacotherapy|November 17, 2023
Urinary biomarkers as indicators of acute kidney injury in critically ill children exposed to vancomycinAutumn M Spyhalsky, Se Jin Kim, Calvin J Meaney, et al.The AAPS Journal|March 1, 2014
A priori prediction of tumor payload concentrations: preclinical case study with an auristatin-based anti-5T4 antibody-drug conjugateDhaval K Shah, Lindsay E King, Xiaogang Han, et al.ACS Nano|April 16, 2024
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model ProteinIngrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, et al.The AAPS Journal|April 1, 2016
Evolution of Antibody-Drug Conjugate Tumor Disposition Model to Predict Preclinical Tumor Pharmacokinetics of Trastuzumab-Emtansine (T-DM1)Aman P Singh, Katie F Maass, Alison M Betts, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 10, 2018
Establishing in vitro-in vivo correlation for antibody drug conjugate efficacy: a PK/PD modeling approachDhaval K Shah, Frank Loganzo, Nahor Haddish-Berhane, et al.Pageof 12